US3769319A - N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester - Google Patents

N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester Download PDF

Info

Publication number
US3769319A
US3769319A US00150169A US3769319DA US3769319A US 3769319 A US3769319 A US 3769319A US 00150169 A US00150169 A US 00150169A US 3769319D A US3769319D A US 3769319DA US 3769319 A US3769319 A US 3769319A
Authority
US
United States
Prior art keywords
carbamic acid
ethyl
trifluoromethylphenyl
propyl
ethyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00150169A
Other languages
English (en)
Inventor
K Boltze
D Lorenz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke Dinklage and Co
Original Assignee
Troponwerke Dinklage and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Dinklage and Co filed Critical Troponwerke Dinklage and Co
Application granted granted Critical
Publication of US3769319A publication Critical patent/US3769319A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids

Definitions

  • This invention relates to' new substituted N-(trifluoromethylphenylethyl)-carbamic acid esters of the general formula @oH -h-iI-c-o-R. mo in. ii (I) wherein the trifluoromethyl group may occupy the ortho, meta or para positions on the phenyl ring, R, is hydrogen or a lower alkyl radical with up to 3 carbon atoms, R is hydrogen or a lower alkyl radical with up to 3 carbon atoms with the proviso that if R, is hydrogen, R is an alkyl radical, and R represents an alkyl radical with 1 to 4 carbon atoms.
  • the compounds according to the invention exhibit a very good appetite-inhibiting effectiveness, which approximately corresponds tothat of compounds presently used for this purpose in human medicine.
  • they do not show any stimulating and motility-increasing effect even in sublethal dosage and are characterized in particular by good compatibility and low toxicity.
  • N-ethyl-N-[l-(m-trifluoromethylphenyl)-propyl-(2)]-carbamic acid ethyl ester an LD of 1,000 mg./kg.
  • R is hydrogen
  • R R and R are defined previously.
  • N [Z-methyl-1-(p-trifluoromethylphenyl)-propyl-(2) carbamic acid ethyl ester also has an LD of only ap proximately 2,000 mg./kg.
  • the compounds according to the invention are about five to ten times less toxic than N ethyl-l-(m-trifluoromethylphenyl)-propylamine- (2).
  • Their appetite-inhibiting etfect is, however, only about two to three times less so that their therapeutic range is two to three times larger. They can, therefore, be handled with'considerably greater safety in human medicine than the preparations used thus far for this purpose.
  • N ethyl 1 (m trifiuoromethylphenyl) propylamine- (2) having a boiling point of 98 to 100 C./1O mm. Hg and a refractive index of 11 1.4545 is obtained.
  • Part 3 1.0 mole of N-ethyl-l-(m-trifiuoromethylphenyl)-propylamine-(Z) from Part 2 in 96% alcohol is added drop by drop at approximately 0 C. to a solution of 1.1 moles of chloroformic acid ethyl ester in 96% alcohol while stirring and cooling and then, in the course of 20 minutes, it is mixed with an aqueous saturated potassium hydrogen carbonate solution. After stirring for three hours. the alcohol is distilled off, the residue absorbed in ether, dried with sodium sulfate and freed of the ether.
  • EXAMPLE 2 6 grams of 2-methyl-l-(p-trifluoromethylphenyll-propylamine-(Z) are dissolved in ethylene chloride and mixed with a solution of 3.1 g. of chloroformic acid ethyl ester in ethylene chloride while stirring. Subsequently an aqueous solution of 2.9 g. of potassium hydrogen carbonate is C. and the reaction mixture added drop by drop at 4-6 C. The separated ethis stirred for several hours at 20 ylene chloride phase is washed with water, filtered and 2.17 g.
  • EXAMPLE 4 2.31 g. (0.01 mole) of N-ethyl-l-(m-trifluoromethyl- I phenyl)-propylamlne-(2) are dissolved in benzene. Phos gene is introduced in the presence of some pyridine while pp. 570 and 571 relied on.
  • N-ethyl-N-[l- (m trifluoromethylphenyl) propyl (2)]carbamic acid chloride is first taken up in ether and then mixed with ethanol. After shaking with water, drying over sodium sulfate and removal of the solvent and recrystallization in etroleum ether, 2.45 g. (80.7% of the theoretical yield) of N ethyl-N-[1-(mtrifluoromethylphenyl)propyl-(2)1 carbamic acid ethyl ester which is identical'with thecompound obtained in Example 1 are obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
US00150169A 1971-06-04 1971-06-04 N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester Expired - Lifetime US3769319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15016971A 1971-06-04 1971-06-04

Publications (1)

Publication Number Publication Date
US3769319A true US3769319A (en) 1973-10-30

Family

ID=22533379

Family Applications (2)

Application Number Title Priority Date Filing Date
US787097D Pending USB787097I5 (enrdf_load_stackoverflow) 1971-06-04
US00150169A Expired - Lifetime US3769319A (en) 1971-06-04 1971-06-04 N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US787097D Pending USB787097I5 (enrdf_load_stackoverflow) 1971-06-04

Country Status (1)

Country Link
US (2) US3769319A (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215139A (en) * 1978-03-17 1980-07-29 Hoffmann-La Roche Inc. Carbamic acid derivatives
US5587398A (en) * 1994-06-03 1996-12-24 David R. Elmaleh Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
US5736573A (en) * 1996-07-31 1998-04-07 Galat; Alexander Lipid and water soluble derivatives of drugs
US6004990A (en) * 1994-06-03 1999-12-21 Zebra Pharmaceuticals Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
EP3170807A1 (en) 2015-11-23 2017-05-24 Frau Pharma S.r.l. New method for synthesis of fenfluramine, of isomers therof and/or of analogs thereof, and new compositions comprising it

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215139A (en) * 1978-03-17 1980-07-29 Hoffmann-La Roche Inc. Carbamic acid derivatives
US5587398A (en) * 1994-06-03 1996-12-24 David R. Elmaleh Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
US6004990A (en) * 1994-06-03 1999-12-21 Zebra Pharmaceuticals Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
US6313175B1 (en) 1994-06-03 2001-11-06 Biostream, Inc. Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
US5736573A (en) * 1996-07-31 1998-04-07 Galat; Alexander Lipid and water soluble derivatives of drugs
EP3170807A1 (en) 2015-11-23 2017-05-24 Frau Pharma S.r.l. New method for synthesis of fenfluramine, of isomers therof and/or of analogs thereof, and new compositions comprising it

Also Published As

Publication number Publication date
USB787097I5 (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
US3928412A (en) 1-Aryloxy-3-ureidoalkylamino-2-propanols
CA2212326C (en) O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
US2714607A (en) Polyethoxy esters of p-butylaminobenzoic acid
Kondo et al. Studies on development of sufficiently chemoselective N-acylation reagents: N-Acyl-N-(2, 3, 4, 5, 6-pentafluorophenyl) methanesulfonamides
EP0024382A1 (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
EP0581167B1 (en) Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria
CA2240060C (en) O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
US2762842A (en) N-aryl-n'-aminoalkyl-ureas
AU2003229734B2 (en) Hydroxy tetrahydro-naphthalenylurea derivatives
US2870151A (en) Mqrpholine -ethers
US3769319A (en) N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester
US3746751A (en) 1-(3-chloro-4-cycloalkylphenyl)-cyclo-alkyl-1-carboxylic acids
AU9015791A (en) 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities
Browne et al. Isomeric Amino Alcohols from the Reaction of Styrene Oxide with Benzylamine
US2126329A (en) Amide derivatives of isoxazole carboxylic acids
AU2002256960B2 (en) New phenylalkyloxy-phenyl derivatives
JPS6317823B2 (enrdf_load_stackoverflow)
US2574150A (en) Acenaphthenyl amino alcohols
US3467705A (en) Neurotropic amides from n-substituted aminomethyl-nor-camphane and a procedure for their preparation
CA1090366A (en) N-substituted aralkylanilines having hypolipidaemic activity
US2695309A (en) Method of preparing 2-acetamino-1-acetoxy-3-oxo-3-phenylpropane
US2906777A (en) N-acylated hydroxybenzylamino phenols
AU2009275667A1 (en) Process for the preparation of O-desmethylvenlafaxine
US3649687A (en) 1 3 5-cyclohexane tricarbonyl chloride
US3079302A (en) O[n-di-(chloroalkyl)carbamoyl] serine